Roberta Cavalli
Overview
Explore the profile of Roberta Cavalli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
169
Citations
2501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohamed S, Cavalli R, Rombi E, Atzori L, Armandi M, Onida B
J Mater Sci Mater Med
. 2025 Feb;
36(1):18.
PMID: 39907851
Hemorrhages are still considered a common cause of death and despite the availability of different hemostatic agents it is still necessary to develop more effective hemostats for bleeding managements in...
2.
Argenziano M, Spagnolo R, Cavalli R
Expert Opin Drug Deliv
. 2025 Feb;
22(3):307-309.
PMID: 39903218
No abstract available.
3.
Mossenta M, Argenziano M, Capolla S, Busato D, Durigutto P, Mangogna A, et al.
Nanomedicine (Lond)
. 2025 Jan;
20(3):255-270.
PMID: 39815170
Background: Drug delivery strategies using chitosan nanobubbles (CS-NBs) could be used to reduce drug side effects and improve outcomes in hepatocellular carcinoma (HCC) treatment. To enhance their action, a targeting...
4.
Di Cintio F, Argenziano M, Scomparin A, Capolla S, Busato D, Steffe A, et al.
Nanomedicine (Lond)
. 2024 Dec;
20(1):23-36.
PMID: 39620421
Background: Recently, we developed AT101, an IgM-class mouse monoclonal antibody directed against glypican-1 (GPC1), a proteoglycan that can be considered as useful target for glioblastoma multiforme (GBM) treatment being specifically...
5.
Balogh B, Peto A, Haimhoffer A, Sinka D, Kosa D, Feher P, et al.
Gels
. 2024 Nov;
10(11).
PMID: 39590031
Psoriasis is an immune-mediated skin condition. There are many therapeutic options for its treatment; however, none of them is completely effective. Tapinarof is a promising new active substance; it was...
6.
Liu X, Wu Z, Cavalli R, Manzoli M, Cravotto G
AAPS PharmSciTech
. 2024 Jul;
25(6):165.
PMID: 39009915
CaCO nanoparticles (nano-CaCO) as nano-templates were prepared using CaCl and NaCO solutions under controlled sonication (19.5 kHz). Using the same ultrasonic device, subsequently, hollow mesoporous silica nanoparticles (HMSNs) were obtained...
7.
Rubeo C, Giordano M, Tannous M, Duran A, Comita S, Landolfi V, et al.
Vascul Pharmacol
. 2024 Jul;
155:107346.
PMID: 38985624
No abstract available.
8.
Rubeo C, Hoti G, Giordano M, Molinar C, Aragno M, Mantuano B, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38891873
Gas-loaded nanocarriers (G-LN) show promise in improving heart transplantation (HTx) outcomes. Given their success in reducing cell death during normothermic hypoxia/reoxygenation (H/R) in vitro, we tested their integration into cardioplegic...
9.
Arduino I, Francese R, Civra A, Feyles E, Argenziano M, Volante M, et al.
Antiviral Res
. 2024 Apr;
226:105897.
PMID: 38685531
Human respiratory viruses have an enormous impact on national health systems, societies, and economy due to the rapid airborne transmission and epidemic spread of such pathogens, while effective specific antiviral...
10.
Ficiara E, Stura I, Vernone A, Silvagno F, Cavalli R, Guiot C
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38397013
Iron overload in many brain regions is a common feature of aging and most neurodegenerative diseases. In this review, the causes, mechanisms, mathematical models, and possible therapies are summarized. Indeed,...